Retinal imaging identifies abusive brain trauma

Data from the ongoing phase 1/2 CHORD trial was presented at the ASGCT annual conference.

Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.

The decision makes givinostat the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.

The approach can improve mental health and various subgroups such as cognitive function, psychological well-being, and more.

William Gallentine, DO, explains why he is excited for the year ahead when it comes to epilepsy treatment as new technologies emerge and the treatment landscape changes.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.